Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zorzetto MMC"'
Autor:
de Pádua Souza C; Barretos Cancer Hospital, Barretos, SP, Brazil. crispadua10@gmail.com., Carneiro ASB; Barretos Cancer Hospital, Barretos, SP, Brazil., de Oliveira Lessa AC; Barretos Cancer Hospital, Barretos, SP, Brazil., Lacerda DC; Barretos Cancer Hospital, Barretos, SP, Brazil., Paiva CE; Barretos Cancer Hospital, Barretos, SP, Brazil., Zorzetto MMC; Barretos Cancer Hospital, Barretos, SP, Brazil., de Freitas AJA; Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos, SP, Brazil., Santana IVV; Pathology Department, Barretos Cancer Hospital, Barretos, SP, Brazil., de Oliveira MA; Nucleus of Epidemiology and Biostatistics, Barretos Cancer Hospital, Barretos, SP, Brazil., Palmero EI; Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos, SP, Brazil.; Department of Genetics, Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Marques MMC; Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos, SP, Brazil., Reinert T; Oncoclinicas, Porto Alegre, Brazil.; Grupo Brasileiro de Estudos em Câncer de Mama (GBECAM), Porto Alegre, Brazil.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 57-65. Date of Electronic Publication: 2023 Aug 14.
Autor:
Testa L; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.; Oncologia D'or, Sao Paulo, SP, BR., Mano M; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Arai RJ; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Bonadio RC; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.; Oncologia D'or, Sao Paulo, SP, BR., Serrano SV; Hospital de Cancer de Barretos, Fundaçao Pio XII, Barretos, SP, BR., Zorzetto MMC; Hospital de Cancer de Barretos, Fundaçao Pio XII, Barretos, SP, BR., Crocamo S; Instituto Nacional do Cancer - INCA, Rio de Janeiro, RJ, BR., Smaletz O; Recepta Biopharma e Hospital Israelita Albert Einstein, Sao Paulo, SP, BR., Freitas-Junior R; Universidade Federal de Goias, Goiania, GO, BR., Hoff PM; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.; Oncologia D'or, Sao Paulo, SP, BR.
Publikováno v:
Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2021 Oct 11; Vol. 76, pp. e3146. Date of Electronic Publication: 2021 Oct 11 (Print Publication: 2021).
Autor:
Pegram MD; Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, 900 Blake Wilbur, Stanford, CA, 94305, USA., Bondarenko I; Oncology and Medical Radiology Department, Dnipropetrovsk Medical Academy, 31 Blyzhnya Street, Dnipro, 49102, Ukraine., Zorzetto MMC; Department of Clinical Oncology, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331 - Dr. Paulo Prata, Barretos, São Paulo, 14784-400, Brazil., Hingmire S; Department of Oncology, Deenanath Mangeshkar Hospital and Research Centre, Erandawne, Pune, Maharashtra, 411004, India., Iwase H; Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Science, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Krivorotko PV; Department of Breast Tumors, Petrov Research Institute of Oncology, 68 Leningradskaya Street, Pesochny, 197758, Saint Petersburg, Russian Federation., Lee KS; Center for Breast Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, Republic of Korea., Li RK; Section of Medical Oncology, Cancer Institute, St. Luke's Medical Center, 279 E Rodriguez Sr. Ave, Quezon City, 1112, Metro Manila, Philippines., Pikiel J; Copernicus, Wojewódzkie Centrum Onkologii, Al. Zwycięstwa 31/32, 80-210, Gdańsk, Poland., Aggarwal R; Pfizer Essential Health, Worldwide Safety, Pfizer Inc, 235 East 42nd Street, New York, NY, 10017, USA., Ewesuedo R; Pfizer Essential Health, Biosimilars Clinical R&D, Pfizer Inc, 610 Main Street, Cambridge, MA, 02139, USA. reginald.ewesuedo@pfizer.com., Freyman A; Pfizer Essential Health, Biosimilars Clinical R&D, Pfizer Inc, 610 Main Street, Cambridge, MA, 02139, USA., Li R; Early Clinical Development Statistics, Pfizer Inc, 1 Portland Street, Cambridge, MA, 02139, USA., Vana A; Pfizer Essential Health, Biosimilars Clinical R&D, Pfizer Inc, 10777 Science Center Drive, San Diego, CA, 92121, USA., Yin D; Clinical Pharmacology, Pfizer Inc, 10777 Science Center Drive, San Diego, CA, 92121, USA., Zacharchuk C; Pfizer Essential Health, Biosimilars Clinical R&D, Pfizer Inc, 610 Main Street, Cambridge, MA, 02139, USA., Tan-Chiu E; Medical Oncology, Florida Cancer Research Institute, 201 NW 82nd Avenue, Suite 102, Plantation, FL, 33324, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2019 Jan; Vol. 120 (2), pp. 172-182. Date of Electronic Publication: 2018 Dec 20.